Enlivex (NASDAQ: ENLV) Announces Positive Result Of Allocetra In COVID-19 Patients
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has revealed today that the clinical trial of AllocetraTM has shown positive results in COVID-19 patients who were in critical